We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$463M
AUM Growth
+$88.4M
Cap. Flow
+$76.3M
Cap. Flow %
16.48%
Top 10 Hldgs %
15.82%
Holding
310
New
106
Increased
69
Reduced
87
Closed
41

Top Buys

Rank Stock Value
1
PFPT
Proofpoint, Inc.
PFPT
+$5.74M
2
LJPC
La Jolla Pharmaceutical Company
LJPC
+$5.51M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.03M
4
IMPV
Imperva, Inc.
IMPV
+$4.56M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$2.3M

Top Sells

Rank Stock Value
1
TEN
Tenneco Inc. Class A Voting Common Stock
TEN
+$4.9M
2
TSCO icon
Tractor Supply
TSCO
+$4.44M
3
LPNT
LifePoint Health, Inc.
LPNT
+$3.96M
4
WCC
WESCO International
WCC
+$3.55M
5
IDTI
Integrated Device Technology I
IDTI
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 15.33%
2 Technology 14.58%
3 Industrials 10.71%
4 Consumer Staples 7.92%
5 Materials 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAYX icon
51
Paychex
PAYX
$40.2B
$2.52M 0.54%
36,973
+66
+0.2% +$4.33K
GILD icon
52
Gilead Sciences
GILD
$162B
$2.5M 0.54%
34,901
+162
+0.5% +$12.3K
INTC icon
53
Intel
INTC
$482B
$2.5M 0.54%
54,146
+914
+2% +$39.9K
WEC icon
54
WEC Energy
WEC
$37.6B
$2.48M 0.53%
37,263
+188
+0.5% +$12.6K
ED icon
55
Consolidated Edison
ED
$41.6B
$2.41M 0.52%
28,415
+169
+0.6% +$14.5K
DUK icon
56
Duke Energy
DUK
$101B
$2.37M 0.51%
28,207
-3
-0% -$262
VGR
57
DELISTED
Vector Group Ltd.
VGR
$2.33M 0.5%
162,179
+2,557
+2% +$35.6K
VER
58
DELISTED
VEREIT, Inc.
VER
$2.26M 0.49%
57,976
-954
-2% -$38.3K
KMB icon
59
Kimberly-Clark
KMB
$36.1B
$2.25M 0.49%
18,627
+201
+1% +$23.4K
LYB icon
60
LyondellBasell Industries
LYB
$19.6B
$2.23M 0.48%
20,222
+867
+4% +$89.9K
PM icon
61
Philip Morris
PM
$302B
$2.23M 0.48%
21,103
+141
+0.7% +$15K
ABBV icon
62
AbbVie
ABBV
$458B
$2.19M 0.47%
22,701
-80
-0.4% -$7.54K
SNY icon
63
Sanofi
SNY
$104B
$2.18M 0.47%
50,601
+1,839
+4% +$84.8K
BUD icon
64
AB InBev
BUD
$158B
$2.15M 0.46%
19,253
+28
+0.1% +$3.29K
CME icon
65
CME Group
CME
$91B
$2.14M 0.46%
14,673
+100
+0.7% +$14.2K
KHC icon
66
Kraft Heinz
KHC
$30.2B
$2.14M 0.46%
27,492
-1,424
-5% -$112K
OTTR icon
67
Otter Tail
OTTR
$3.88B
$2.14M 0.46%
48,101
+456
+1% +$20.9K
BXMT icon
68
Blackstone Mortgage Trust
BXMT
$2.82B
$2.08M 0.45%
64,595
+1,041
+2% +$33.4K
EQR icon
69
Equity Residential
EQR
$25.4B
$2.08M 0.45%
32,568
+268
+0.8% +$17.9K
CVS icon
70
CVS Health
CVS
$137B
$2.06M 0.45%
28,485
-9,811
-26% -$713K
SAFT icon
71
Safety Insurance
SAFT
$1.51B
$1.89M 0.41%
23,486
+83
+0.4% +$6.71K
PSX icon
72
Phillips 66
PSX
$83.1B
$1.87M 0.4%
18,509
+116
+0.6% +$11K
VOO icon
73
Vanguard S&P 500 ETF
VOO
$971B
$1.87M 0.4%
7,611
-750
-9% -$179K
MET icon
74
MetLife
MET
$60.2B
$1.65M 0.36%
32,545
+1,937
+6% +$102K
CYBR
75
DELISTED
CyberArk
CYBR
$1.54M 0.33%
37,189
-17,667
-32% -$774K
1 2
3
4 5

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q4 2017 Portfolio in Review

As of Q4 2017, Stanley-Laman Group held 310 positions worth $463M, up 24% from $375M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group deployed $76.3M of net new capital in Q4 2017, opening 106 new positions and adding to 69 existing holdings. Its largest new stake was La Jolla Pharmaceutical Company: 168,653 shares worth $5.43M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was JBT Marel, an estimated $889K trimmed.

  • Stanley-Laman Group's largest Q4 2017 buy was La Jolla Pharmaceutical Company: 168,653 shares worth $5.43M.
  • Stanley-Laman Group added most to Proofpoint, Inc. in Q4 2017, an estimated $5.74M increase.
  • Stanley-Laman Group's biggest Q4 2017 reduction was JBT Marel, cutting an estimated $889K.
  • Stanley-Laman Group fully exited Tenneco Inc. Class A Voting Common Stock in Q4 2017, selling an estimated $4.9M.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $463M portfolio in Q4 2017.
  • Stanley-Laman Group opened 106 new positions and closed 41 in Q4 2017.
  • Stanley-Laman Group's portfolio value rose 24% quarter-over-quarter to $463M.

Based on Stanley-Laman Group's 13F filing for Q4 2017, filed 9 Feb 2018.